Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors

J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):602-9. doi: 10.1002/jhbp.209. Epub 2015 Jan 26.

Abstract

Functioning pancreaticoduodenal neuroendocrine tumors (PD-NETs) are popular in a textbook, but they are still unfamiliar to a general clinician, and delay of diagnosis or misdiagnosis has been reported even today. It is a consensus that sporadic functioning PD-NET is cured only by surgical resection. So, early detection and early resection is the gold standard for the treatment of functioning PD-NET. Functioning PD-NETs in patients with multiple endocrine neoplasia type 1 (MEN 1) are often multiple. You should check about MEN 1 whenever you encountered multiple PD-NET. They are diagnosed in younger age than sporadic cases. In most cases they are accompanied with numerous microscopic or macroscopic nonfunctioning P-NETs, which are potentially metastatic and the most common cause of death in MEN 1 patients.

Keywords: Functioning duodenal neuroendocrine tumor; Functioning pancreaticoduodenal neuroendocrine tumor; Gastrinoma; Insulinoma.

MeSH terms

  • Diagnosis, Differential
  • Duodenal Neoplasms / diagnosis*
  • Duodenal Neoplasms / physiopathology
  • Glucagonoma / diagnosis
  • Humans
  • Insulinoma / diagnosis
  • Multiple Endocrine Neoplasia Type 1 / diagnosis
  • Neuroendocrine Tumors / diagnosis*
  • Neuroendocrine Tumors / physiopathology
  • Pancreatic Neoplasms / diagnosis*
  • Pancreatic Neoplasms / physiopathology